BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Ask first for evidence-based, FDA‑approved hormone therapy (HRT) through your primary care doctor or an OB/GYN/menopause specialist.
• Only consider compounded “bioidentical” hormone therapy (BHRT) after a clear discussion of risks/benefits, and only from a state‑licensed compounding pharmacy with accreditation if there’s a specific need that FDA products can’t meet.

What they are (brief)

• Traditional HRT: FDA‑approved preparations of estradiol, conjugated estrogens, and progesterone or progestins. Doses and safety have been studied in large trials and guidelines. Examples: Estrace (oral estradiol), Vivelle‑Dot or Climara (estradiol patches), Vagifem (low‑dose vaginal estradiol tablet), Prometrium (micronized progesterone).
• “BHRT” (often called compounded bioidentical): custom‑made hormone mixes from compounding pharmacies. Ingredients may be chemically identical to human hormones (eg, estradiol, progesterone), but compounded products are not reviewed by the FDA for consistent dose, purity, or safety and lack large‑scale outcome data.

Pros/cons

• Traditional HRT pros: standardized dosing, FDA quality control, evidence‑based safety/efficacy data, wide range of routes (oral, transdermal, vaginal). Cons: may not be individually compounded.
• Compounded BHRT pros: customizable dosing/forms, appealed to people wanting “natural” formulations. Cons: variable quality, inconsistent dosing, limited safety data, often higher cost, and many providers/labs use unvalidated tests to “tailor” therapy.

What the major clinical groups say

• Organizations like the North American Menopause Society (NAMS) and the Endocrine Society recommend FDA‑approved products as first line and caution against using saliva testing to dose hormones or routine use of compounded BHRT.

Who should consider which

• If you have typical menopausal symptoms (hot flashes, night sweats, vaginal dryness) and no unusual allergy/need: start with FDA‑approved HRT; choose route based on symptoms and risk (eg, low‑dose vaginal estrogen for only vaginal symptoms).
• Consider compounded BHRT only if you’ve had adverse effects to available FDA options or need a very specific dose/formulation that can’t be obtained commercially — and after discussing the tradeoffs and using a reputable compounding pharmacy.

Where to ask / who to see

• Start: your primary care clinician or OB/GYN. Tell them your main symptoms, health history (blood clots, stroke, heart disease, breast cancer), family history, and what you’d like to achieve.
• For specialized care: see a menopause specialist or NAMS‑certified practitioner. Search NAMS “Find a Menopause Practitioner” on their site.
• Larger centers with menopause programs: Mayo Clinic Menopause Clinic, Cleveland Clinic Women’s Health, or your local academic medical center.
• If you’re offered compounded BHRT: ask which compounding pharmacy will supply it and verify the pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB) or state board.

Practical recommendations (what to ask your clinician)

• “What are my non‑hormonal and hormonal options for these symptoms?”
• “Can you explain the risks and benefits for me given my medical history?”
• “Why would you recommend an oral vs transdermal vs vaginal route?”
• “Are there FDA‑approved products that would meet my needs?” (If yes, ask specifics.)
• “If you recommend compounded BHRT, why is that preferred over FDA‑approved therapy, and which accredited pharmacy will make it?”
• “Will you use saliva hormone tests to guide dosing?” (Most experts advise against that—don’t rely on saliva tests.)

Specific products worth knowing (examples)

• Estradiol patches: Vivelle‑Dot, Climara — good for systemic estrogen with steady delivery and potentially lower clot risk than some oral estrogens.
• Oral estradiol: Estrace — commonly used systemic option.
• Vaginal/local estrogen: Vagifem (vaginal tablet), Estring (vaginal ring) — good for local vaginal dryness/urgency with minimal systemic exposure.
• Progesterone for endometrial protection: Prometrium (micronized progesterone) — FDA‑approved and commonly used.

Monitoring and safety

• Your clinician will review breast cancer screening (mammogram), blood clot history, and cardiovascular risk before starting. Baseline labs aren’t always required, but routine follow‑up to reassess symptoms and risks is standard.
• Beware claims that compounded BHRT is safer or proven to prevent heart disease or dementia—those claims aren’t supported by high‑quality evidence.

Bottom line For most people, ask for evidence‑based, FDA‑approved HRT (choice of product/route individualized). Use compounded BHRT only if there’s a clear, specific reason and you’ve discussed quality and safety with your clinician — and get the product from an accredited compounding pharmacy. If you want help finding a menopause specialist, tell me your city or ZIP and I can point to local options.